Home > Concentration-dependent activity of hydromethylthionine on clinical decline and brain atrophy in a randomized controlled trial in behavioral variant frontotemporal dementia
Concentration-dependent activity of hydromethylthionine on clinical decline and brain atrophy in a randomized controlled trial in behavioral variant frontotemporal dementia
Manuscript Number:
19-1173R1
Author(s):
Thomas C. Baddeley, Peter Bentham, Luc Bracoud, Harish Ganesan, Serge Gauthier, Jeffrey Hammel, Jiri H. Hardlund, Charles R. Harrington, Jianping Jia, Christopher Kipps, Karin A. Kook, Hans J. Moebius, Alison Murray, Gernot Riedel, Christopher M. Rubino, Björn O. Schelter, Helen Shiells, Roger T. Staff, John M.D. Storey, Vesna Vuksanovic, Claude M. Wischik, Damon J. Wischik
